Your browser doesn't support javascript.
loading
Letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by P. Barrière, S. Hamamah, E. Arbo, C. Avril, B. Salle, J.-L. Pouly, et al. (J Gynecol Obstet Hum Reprod. 2023;52(1):102510).
Montenegro, Susana; Helwig, Christoph; Schwarze, Juan-Enrique; Castello-Bridoux, Claire; Marque, Sebastien; Lispi, Monica; D'Hooghe, Thomas.
Afiliación
  • Montenegro S; Merck KGaA, Darmstadt, Germany. Electronic address: susana.montenegro@merckgroup.com.
  • Helwig C; Merck KGaA, Darmstadt, Germany.
  • Schwarze JE; Merck KGaA, Darmstadt, Germany.
  • Castello-Bridoux C; Merck Santé, France, an affiliate of Merck KGaA, Darmstadt, Germany.
  • Marque S; Horiana company, Bordeaux, France.
  • Lispi M; Merck KGaA, Darmstadt, Germany; Unit of Endocrinology, PhD School of Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Reggio Emilia 42121, Italy.
  • D'Hooghe T; Merck KGaA, Darmstadt, Germany; Department of Development and Regeneration, Laboratory of Endometrium, Endometriosis & Reproductive Medicine, KU Leuven, Leuven, Belgium; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University Medical School, New Haven, United States.
J Gynecol Obstet Hum Reprod ; 52(8): 102640, 2023 10.
Article en En | MEDLINE | ID: mdl-37549879
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Biosimilares Farmacéuticos País/Región como asunto: Europa Idioma: En Revista: J Gynecol Obstet Hum Reprod Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Biosimilares Farmacéuticos País/Región como asunto: Europa Idioma: En Revista: J Gynecol Obstet Hum Reprod Año: 2023 Tipo del documento: Article